Chemicals and Drugs

Rituximab

A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

9 entry terms
  • CD20 Antibody, Rituximab
  • Rituximab CD20 Antibody
  • GP2013
  • IDEC-C2B8
  • IDEC-C2B8 Antibody
  • Mabthera
  • Rituxan
  • IDEC C2B8
  • IDEC C2B8 Antibody

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (1995)

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. Rituximab. Medical Subject Headings (MeSH). 2026. Unique ID D000069283. http://id.nlm.nih.gov/mesh/2026/D000069283
  2. Rituximab. In: Wikipedia. https://en.wikipedia.org/wiki/Rituximab
  3. Rituximab. In: Wikidata. https://www.wikidata.org/wiki/Q412323